This CDK9 mediated tumorigenic step has seen increasing attention within the literature and has been implicated in pancreatic cancer, hypopharyngeal carcinoma, leukemia, breast cancer, and hepatocellular carcinoma 13-17. This evidence concerns the gene CDK9 and familial pancreatic carcinoma.